281 related articles for article (PubMed ID: 31047772)
1. Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.
Li Y; Zhang Y; Li X; Yi S; Xu J
Trends Biochem Sci; 2019 Aug; 44(8):659-674. PubMed ID: 31047772
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Variomics and Multi-omics Network Biology for Precision Medicine.
Li MM; Awasthi S; Ghosh S; Bisht D; Coban Akdemir ZH; Sheynkman GM; Sahni N; Yi SS
Methods Mol Biol; 2023; 2660():357-372. PubMed ID: 37191809
[TBL] [Abstract][Full Text] [Related]
3. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
4. Identification of genomic features in the classification of loss- and gain-of-function mutation.
Jung S; Lee S; Kim S; Nam H
BMC Med Inform Decis Mak; 2015; 15 Suppl 1(Suppl 1):S6. PubMed ID: 26043747
[TBL] [Abstract][Full Text] [Related]
5. Functional variomics and network perturbation: connecting genotype to phenotype in cancer.
Yi S; Lin S; Li Y; Zhao W; Mills GB; Sahni N
Nat Rev Genet; 2017 Jul; 18(7):395-410. PubMed ID: 28344341
[TBL] [Abstract][Full Text] [Related]
6. Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy.
Alexandrova EM; Moll UM
Cell Death Differ; 2017 Jan; 24(1):3-5. PubMed ID: 27935583
[No Abstract] [Full Text] [Related]
7. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
Gene; 2019 May; 697():57-66. PubMed ID: 30796966
[TBL] [Abstract][Full Text] [Related]
8. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
9. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
Stiewe T; Haran TE
Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
[TBL] [Abstract][Full Text] [Related]
10. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
Sun S; Thorson JA; Murray SS
Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
[TBL] [Abstract][Full Text] [Related]
11. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
[TBL] [Abstract][Full Text] [Related]
12. From mutational inactivation to aberrant gain-of-function: Unraveling the structural basis of mutant p53 oncogenic transition.
Olotu FA; Soliman MES
J Cell Biochem; 2018 Mar; 119(3):2646-2652. PubMed ID: 29058783
[TBL] [Abstract][Full Text] [Related]
13. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
Mercatanti A; Lodovichi S; Cervelli T; Galli A
FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
15. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants.
Petersen J; Staab J; Bader O; Buhl T; Ivetic A; Meyer T
Mol Immunol; 2019 Oct; 114():30-40. PubMed ID: 31336247
[TBL] [Abstract][Full Text] [Related]
16. Base-resolution stratification of cancer mutations using functional variomics.
Yi S; Liu NN; Hu L; Wang H; Sahni N
Nat Protoc; 2017 Nov; 12(11):2323-2341. PubMed ID: 28981122
[TBL] [Abstract][Full Text] [Related]
17. Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.
Karageorgos I; Mizzi C; Giannopoulou E; Pavlidis C; Peters BA; Zagoriti Z; Stenson PD; Mitropoulos K; Borg J; Kalofonos HP; Drmanac R; Stubbs A; van der Spek P; Cooper DN; Katsila T; Patrinos GP
Hum Genomics; 2015 Jun; 9(1):12. PubMed ID: 26092435
[TBL] [Abstract][Full Text] [Related]
18. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
[TBL] [Abstract][Full Text] [Related]
19. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
20. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
